|
C4ORF21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.195400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.090000E-01 |
| Normal-vs-Stage2 |
8.259600E-02 |
| Normal-vs-Stage3 |
3.851800E-02 |
| Normal-vs-Stage4 |
9.469000E-01 |
| Stage1-vs-Stage2 |
1.488180E-01 |
| Stage1-vs-Stage3 |
4.305700E-02 |
| Stage1-vs-Stage4 |
7.594000E-01 |
| Stage2-vs-Stage3 |
9.745000E-01 |
| Stage2-vs-Stage4 |
2.063200E-01 |
| Stage3-vs-Stage4 |
1.648210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.122200E-01 |
| Normal-vs-AfricanAmerican |
5.541800E-01 |
| Normal-vs-Asian |
4.227600E-01 |
| Caucasian-vs-AfricanAmerican |
8.690000E-01 |
| Caucasian-vs-Asian |
8.060800E-01 |
| AfricanAmerican-vs-Asian |
9.885600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.482400E-01 |
| Normal-vs-Female |
1.117390E-01 |
| Male-vs-Female |
2.436000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.753600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.476100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.645400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.826600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.685700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.362200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.940600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.075000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.800800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.856400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.121000E-03 |
| Classical-VS-Follicular |
8.902600E-01 |
| Classical-VS-Other |
4.175000E-01 |
| Classical-VS-Normal |
4.588200E-01 |
| Tall-VS-Follicular |
4.393700E-02 |
| Tall-VS-Other |
2.002400E-01 |
| Tall-VS-Normal |
9.359500E-03 |
| Follicular-VS-Other |
5.651600E-01 |
| Follicular-VS-Normal |
6.321800E-01 |
| Other-VS-Normal |
6.207400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.630400E-01 |
| Normal-vs-N1 |
7.309000E-01 |
| N0-vs-N1 |
2.403600E-01 |
|
|
